FREELEGAL CASE EVALUATION

Please fill out our easy to use form below. We will contact you today. Or, call us 24/7 TOLL FREE at 877-934-6274.
  • MM slash DD slash YYYY

  • By submitting this form you acknowledge that you have read the Terms of Use and accept the terms of this agreement.

NEWS

February 25, 2019: Increased Risk Of Pulmonary Embolism And Death With Higher Dose Of Tofacitinib (Xeljanz, Xeljanz XR) in Rheumatoid Arthritis Patients

FDA Reports – Increased Risk of Pulmonary Embolism and Death Read More

February 5, 2018: FDA Safety Letter Regarding PE and Extracorporeal Photopheresis (ECP) Treatment

FDA Safety Letter Regarding PE and Extracorporeal Photopheresis (ECP) Treatment Read More

July 11, 2016: Alere Withdraws Faulty Blood-Thinner Monitor

Faulty Blood-Thinner Monitor Announcement Regarding Faulty Blood-Thinner Monitor Alere Inc. Read More

November 23, 2015: FDA Reports Lubricious Coating May Separate from Intravascular Medical Devices

According to a November 23, 2015 U.S. Food and Drug Read More

October 13, 2015: World Thrombosis Day – Global Call On Blood Clot Risk Assessment In Hospitals

« Older Entries

CONTACT US

If you have a case-specific question, or a question regarding our legal services, please select
Contact Weinberg Law Firm. You may also call us 24/7 at our toll free number, 1(877) 934-6274.